Novartis India Ltd. - OTC Business Unit, has announced the launch of Otrivin in a Nasal Spray format in Indian market.

It should be noted that Otrivin has been the market leader in the Nasal Decongestant category, and has been trusted by health care professionals for several decades. However, it is now available as an OTC nasal decongestant in spray form that acts directly by constricting the blood vessels in the nasal tissues leading to relief from nasal congestion.

Otrivin formulation comprises of Xylometazoline 0.1% and is indicated for the symptomatic relief of nasal congestion due to colds, seasonal and perennial allergic rhinitis and sinusitis.

In order to apply the nasal spray the consumer needs to hold his head upright and simultaneously spray the medication in a nostril and inhale.

The company claims that the drug acts locally inside the nose within 2 minutes and works for as long as 10 hours.

Otrivin Nasal Spray will be available throughout the country at all leading chemist stores at Rs 44 for a 10 ml unit.